An Efficient UPLC-MS/MS Method Established to Detect Relugolix Concentration in Rat Plasma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.874973
Abstract: Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the CYP3A subfamily of P450 enzymes, while minorly metabolized by CYP2C8. Daidzein in… read more here.
Keywords: efficient uplc; day; daidzein; relugolix ... See more keywords